PTC治疗 PTCT 深 沪
交易中 09-19 12:59:35 美东时间
36.78
+1.300
+3.66%
华盛通- 最 高37.09
- 今 开36.36
- 成交量 19.59万股
- 最 低 36.28
- 昨 收 35.48
- 总市值 27.71亿
- 52周最高 40.69
- 市盈率 静 --
- 换手率 0.26%
- 52周最低 17.53
- 委 比 -73.33%
- 总股本 7534.50万
- 历史最高 78.72
- 量 比 0.73
- 振 幅 2.28%
- 历史最低 4.03
- 每 手 1
- 风险率 5.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ClearPoint Neuro fully repays $10M converted note
ClearPoint Neuro (NASDAQ:CLPT) announced that on August 23, 2024, it provided for the full early repayment of the principal amount and interest on a $10M convertible note held by PTC Therapeutics whic...
08-27 04:13
PTC Therapeutics rises as UBS restarts coverage with buy rating
PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday trading after UBS resumed coverage of the stock with a buy rating. The firm has a $47 price target (~38% upside based on Aug. 23 close). Analyst Elia...
08-26 23:58
PTC Therapeutics: Balancing Strong FY24 Guidance Against Regulatory Uncertainties
In a report released yesterday, Joseph Schwartz from Leerink Partners reiterate...
08-13 21:55
快讯 | ptc therapeutics: 巴克莱银行将目标价从25美元上调至31美元
PTC Therapeutics : Barclays Raises Target Price to $31 From $25
08-09 18:39
快讯 | PTC Therapeutics公司：TD Cowen将目标价从30美元上调至33美元。
PTC Therapeutics Inc : TD Cowen Raises Target Price to $33 From $30
08-09 15:05
快讯 | PTC Therapeutics公司：摩根大通将目标价从53美元降至51美元
PTC Therapeutics Inc : JP Morgan Cuts Target Price to $51 From $53
08-09 11:27
PTC Sees FY24 Revenue $700M-$750M Vs $749M Estimate
PTC Updates Full Year 2024 Financial Guidance: PTC anticipates total revenues for full year 2024 to be between $700 million and $750 million.PTC anticipates GAAP R&D and SG&A expenses for full year 2024 to
08-09 05:23
PTC Therapeutics reports Q2 results
PTC Therapeutics press release (NASDAQ:PTCT): Q2 Revenue of $187M (-12.5% Y/Y) beats by $5.99M. Net loss was $99.2 million for the second quarter of 2024, compared to net loss of $198.9 million for th...
08-09 04:24
PTC Therapeutics Q2 2024 GAAP EPS $(1.29) Misses $(1.19) Estimate, Sales $186.704M Beat $185.319M Estimate
PTC Therapeutics (NASDAQ:PTCT) reported quarterly losses of $(1.29) per share which missed the analyst consensus estimate of $(1.19) by 8.4 percent. The company reported quarterly sales of $186.704 million which beat
08-09 04:08
快讯 | PTC Therapeutics Inc - 2024年Q2总收入为1.867亿美元，较2023年Q2的2.138亿美元减少。
PTC Therapeutics Inc - Total Revenues Were $186.7 Mln for Q2 of 2024, Compared ...
08-09 04:02
